A new project on Early Identification of Stroke is now available for feedback from all interested stakeholders.
Early Identification of Stroke
Call for Feedback: 2020-01-17
Feedback Due By: 2020-01-31
Consultation Document: Horizon Scanning Report
Product Type: Issues in Emerging Health Technologies
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:
A new process for the submission and review of cell and gene therapies
Updated guidelines on fees for CADTH pharmaceutical reviews
Pending updates to the category 1 r...
CADTH has received the following notice(s) of pending drug submission(s).
von Willebrand Factor [recombinant]
Shire Pharma Canada ULC, now part of Takeda
von Willebrand disease, adults, treatment and perioperative management
Today, CADTH has issued final recommendations for:
Indications: hereditary transthyretin amyloidosis
Recommendation: Reimburse with clinical criteria and/or conditions
For more information